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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů “ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ “ŶŽƌĞƐƉŽŶƐĞ ? ? “ĨĂŝů ? ?Žƌ “ƌĞĨĞƌ ? ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x Tested and ƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ “ƉĂƐƐ ?Žƌ “ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ “ƉĂƐƐ ?Žƌ “ƌĞĨƌƚŽ 
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ “ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů “ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg test 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation 
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3. Population and Healthcare Overview 
The population of Estonia is estimated at 1,320,000 (World Bank, 2018a) and birth rate is 
estimated at 10.7 births/1,000 population in 2016 (World Bank, 2018b). The change in 
population and birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B 
respectively. 
Estonia has a reported population density of 31 people per square kilometre in 2017 and 
this has risen from 29 people per square kilometre in 1961 (World Bank, 2018c). In terms 
of healthcare facilities, the total density of hospitals in 2013 was 1.94 per 100,000 
population (WHO, 2016a). Infant mortality in 2017 is estimated at 2.1 deaths/1,000 live 
births in total (World Bank, 2018d). 
The average life expectancy in Estonia is estimated at 77.7 (World Bank, 2018e), with a 
death rate 11.7 deaths/1,000 population in 2016 (World Bank, 2018f). Estonia has a gross 
national income per capita (PPP int. $, 2013) of $24,000 (WHO, 2016b). The estimated total 
expenditure on health per capita in 2014 was $1,668 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 6.4% (WHO, 2016b). 
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Figure 1: Total Population and Birth Rate in Estonia 
 
Source: Information sourced from World Bank (2018) 
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4. Vision Screening Commissioning and Guidance 
Vision screening in Estonia is organised nationally, with no regional variation between 
protocols. Vision screening is performed by family doctors and family nurses. In some cases, 
vision screening is performed by ophthalmologists, orthoptists and optometrists in hospitals 
or private clinics. There are approximately 1700 family doctors and family nurses, per 
million people. There are family doctors and family nurses that do not screen, but could do 
so with additional training. Changes to the national vision screening programme are still in 
progress, the aim is that healthy children will be screened by family doctors and nurses, 
whereas ophthalmologists, orthoptists and optometrists will not screen healthy children. At 
present, as the new regulation by the Ministry of Social Affairs is not in force, some family 
doctors follow old guidelines and do not screen healthy children. Due to the period of 
transition, there is no exact statistical data. Training for family doctors and nurses is 
provided by ophthalmologists and orthoptists, this last for around 4 hours. The training is 
regularly updated, monitored and revalidated, however, this is not yet accredited or 
certified.  
Vision screening is funded through health insurance and it is embedded into a general 
preventative child healthcare screening programme. The content of the vision screening 
programme is decided upon by ophthalmologists and was implemented nationally in 1995. 
Since its application, the vision screening programme has been changed; this change is 
being fulfilled at present, with the addition of family doctors and family nurses as vision 
screeners. 
The national general health screening guideline provides recommendations for vision 
screening to each professional. The vision screening programme is reviewed once every 5 
years, and any revisions are decided upon by the Ministry of Social Affairs through guideline 
revisions set out by the Estonian Ophthalmological Society. There are no methods for 
quality monitoring of vision screening imposed by the government.  
There is no research carried out in Estonia regarding the vision screening programme, or the 
cost-effectiveness and overall effectiveness of the vision screening programme.  
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5. Screening programme  
In Estonia, the target conditions for vision screening are retinopathy of prematurity and  
reduced visual acuity measured at 3 years  and again at 6 years of age. The health care 
professionals delivering vision screening, venue for screening and tests used vary depending 
on the age of the child as shown in Tables 1, 2 and 3 respectively. Specific details of the 
screening offered within each age group are described more fully in sections 5.1 to 5.4 
below. 
5.1 Vision screening - Preterm babies 
All babies less than 32-weeks gestational age or less than 1500g birthweight are screened 
for retinopathy of prematurity (ROP). The first ROP screening examination is performed 
between 4 to 5-weeks postnatal age. The baby is screened until full retinal vascularisation, 
at least until 40-weeks gestational age. Frequency of follow-up examinations is determined 
by the examining ophthalmologist on the basis of retinal findings. Babies are screened by 
binocular indirect ophthalmoscopy and digital retinal images (Retcam). These tests are 
ĐŽŶĚƵĐƚĞĚďǇĂƉĂĞĚŝĂƚƌŝĐŽƉŚƚŚĂůŵŽůŽŐŝƐƚĂƚĞŝƚŚĞƌĂĐŚŝůĚƌĞŶ ?ƐŚŽƐƉŝƚĂůŽƌĂŶĞǇĞĐůŝŶŝĐĂŶĚ
referral for further diagnostic examination is determined by absence of red reflex, or 
suspicion of eye pathology during eye inspection.  
5.2 Vision screening - Birth to 3 months 
A neonatologist will screen newborns at the maternity hospital, this includes external 
inspection of the eyes and lids and red reflex examination. Family doctors (GP) will then 
screen again during 1-2 weeks of life at an outpatient clinic including external inspection of 
the eyes, lids and red reflex examination. These tests are conducted by either a 
paediatrician, ophthalmologist or a GP at a hospital. Referral for further diagnostic 
examination is determined by absence of red reflex, or suspicion of eye pathology during 
eye inspection. Babies are referred after one abnormal or one inconclusive test and if there 
is any suspicion of pathology.  
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months are screened by a GP in an outpatient clinic. The GP will 
perform the eye inspection and red reflex test at 3 months of age and again at 6 months of 
age, with the addition of fixation, eye motility and Hirschberg. Referral for further diagnostic 
examination at 6 months of age is determined by abnormal tearing, abnormal fixation and 
eye motility abnormalities such as nystagmus and strabismus. At 12 months, the GP will 
conduct assessments using eye inspection, red reflex testing, fixation, eye motility and 
Hirschberg. Any visible eye pathology, abnormal red reflex, strabismus or tearing results in 
the child being referred to ophthalmologist. 
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5.4 Vision screening - 36 months to 7 years 
Children aged 36 months to 7 years are screened using eye inspection, fixation, red reflex 
testing, eye motility, Hirschberg and a visual acuity measurement. At the age of 3 years, 
children are screened using a visual acuity assessment for the first time, this is conducted by 
family nurses using linear crowded Lea Symbols. Visual acuity measurement is repeated at 
age 6 years, by a family nurse. Vision screening is repeated twice after abnormal or 
inconclusive test results, or if there is any suspicion of pathology. Children are referred from 
screening if they fail the visual acuity measurement and this is determined by a visual acuity 
of 2 lines difference between the eyes (both at ages 3 and 6 years old). 
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Table 1: Healthcare professionals who conduct vision screening in each age group  
 Table 1. Neonatologist Nurse Ophthalmologist Orthoptist GP Paediatrician 
Preterm babies  
× × 9 × × × 
0 to 3 months  9 × 9 × 9 9 
3 to 36 months  
× × × × 9 × 
3 to 7 years  
× 9 × × 9 × 
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Table 2: Vision screening tests used in vision screening for each age group  
 Table 2.  Eye 
inspection 
Fixation Red reflex Eye motility Hirschberg 
test 
Retinal 
examination 
Visual acuity 
Preterm babies  9 × 9 × × 9 × 
0 to 3 months  9 × 9 × × × × 
3 to 36 months  9 9 9 9 9 × × 
3 to 7 years  9 9 9 9 9 × 9 
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Table 3: Location of vision screening for each age group  
 Table 3.  Eye Clinic Hospital Outpatient clinic 
Preterm babies  9 9 × 
0 to 3 months  
× 9 × 
3 to 36 months  
× × 9 
3 to 7 years  
× × 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error in infants from 6 months of age. It provides objective results 
and is used to detect amblyopic risk factors. This differs from other methods used to screen 
children for amblyopia which focus on detection of the actual condition and the resulting 
visual loss. Automed vision screening is not used as part of vision screening in Estonia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Summary Vision Screening Data: Estonia                                                                                          
10 
 
7 Provision for Visually Impaired  
In Estonia, there are two schools for the blind or severely visually impaired; Tartu Emajõe 
^ĐŚŽŽů ?ĂĐĐŽŵŵŽĚĂƚĞƐ ? ?ĐŚŝůĚƌĞŶĂŶĚdĂůůŝŶŶ,ĞůĞŶ ?Ɛ^ĐŚŽŽů ?ƐĞǀĞƌĞŚĞĂƌŝŶŐĂŶĚ ?ŽƌǀŝƐƵĂů
impairment) accommodates 156 children. The costs per child for these schools is not 
known. There is special support for visually impaired children who attend regular 
mainstream primary schools via the Social Insurance Agency who purchase magnifying 
glasses and low vision aids once a year.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
The prevalence of treated or untreated amblyopia in Estonia, by age 7 years is estimated at 
2 to 4%. The prevalence of persistent amblyopia by age 7 years is not known. The 
prevalence of strabismus before the age of 7 years is not known. The incidence of the four 
types of amblyopia (strabismic, refractive, combined mechanism and deprivation) are not 
known. 
8.2 Coverage 
In Estonia, it is estimated that 14,500 children are screened each year, by the age of 3 years. 
Family nurses invite children for their general preventative health screening and that this is 
done via the telephone but there is no data available regarding the number of children 
invited for vision screening. The coverage and attendance rates of vision screening is not 
known. The percentage of compliance with referral after an abnormal screening test result 
is not known and there is no registration or documentation of noncompliance with referral 
after an abnormal screening test result. 
8.3 Screening evaluation 
The percentage of false negative and false positive referrals from vision screening is not 
known. The positive predictive value, sensitivity and specificity of vision screening is not 
known.  
8.4 Treatment success 
The percentage of children treated for strabismus or amblyopia before the age of 7 years is 
not known. The percentage of children treated for congenital eye disorders is not known. 
The number of patients treated for congenital cataract, amblyopia and strabismus each year 
by either an orthoptist or ophthalmologist is not known.  
Paediatric ophthalmologists are the professionals that are employed to prescribe glasses for 
children, under the age of 7 years, after referral from screening. Further treatment options 
include patching and cataract surgery. The aim is to treat all eligible children with vision 
disorders, however, this is not possible, due to capacity problems. There are insufficient 
numbers of ophthalmologists to screen all healthy children, the preferred model is 
screening by family doctors or nurses where there is no capacity problem. A new national 
vision screening programme is in process that will be delivered by family doctors and family 
nurses. 
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9 Costs of vision screening in children 
9.1 Cost of vision screening 
The salary costs per hour for vision screening professionals is not known. It is not known 
how much it costs to train the general preventative child health care screening professionals 
between leaving secondary education to qualification. The total screening costs per year for 
vision screening in Estonia is not known. Vision screening is free of charge, with no reward 
for attending vision screening or penalty for non-attendance. However, vision screening is 
deemed obligatory, although it is unclear how this is enforced.  
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients, with refractive amblyopia and 
strabismic amblyopia, including follow up, is not known.   
9.3 Cost of Treatment for strabismus  
The Estonian Health Insurance Fund estimates the costs for strabismus surgery including 
follow up to be as follows: 
x strabismus surgery 300-400 Euros 
x 1-day hospital stay 100 Euros 
x general anaesthesia 98 Euros 
x recovery room stay 24 Euros   
x Total of 522-622 Euros 
9.4 Cost of treatment for cataract 
The Estonian Health Insurance Fund estimates the costs for cataract surgery including follow 
up  ?to be 530 Euros.  
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